Global Cell Perfusion Systems Market Growth 2025-2031

Publication ID:

LPI07259161

Publication Date:

July 18, 2025

Pages:

130

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturers [2]

Machinery [3]

Industry & Manufacturing [4]

Description:

The global Cell Perfusion Systems market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Perfusion cell culture utilizes a cell retention device and continuous media exchange to achieve and maintain high cell densities and viabilities over extended periods of time.
United States market for Cell Perfusion Systems is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cell Perfusion Systems is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cell Perfusion Systems is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cell Perfusion Systems players cover Repligen, Fluigent, ibidi, Cytiva, Spectrum Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐ell Perfusion Systems Industry Forecast鈥� looks at past sales and reviews total world Cell Perfusion Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Perfusion Systems sales for 2025 through 2031. With Cell Perfusion Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Perfusion Systems industry.
This Insight Report provides a comprehensive analysis of the global Cell Perfusion Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Perfusion Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cell Perfusion Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Perfusion Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Perfusion Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Perfusion Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Recirculating Systems
Non-Recirculating Systems
Segmentation by Application:
Drug Development
Disease Modeling
Personalized Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Repligen
Fluigent
ibidi
Cytiva
Spectrum Medical
Elveflow
Precigenome
Merck KGaA
Harvard Apparatus
Sartorius Stedim Biotech
AutoMate Scientific
REPROCELL
Tokai HIT
Biophysical Tools
3D Biotek
TA Instruments
Takasago Electric
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cell Perfusion Systems market?
What factors are driving Cell Perfusion Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cell Perfusion Systems market opportunities vary by end market size?
How does Cell Perfusion Systems break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Perfusion Systems Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cell Perfusion Systems by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cell Perfusion Systems by Country/Region, 2020, 2024 & 2031
2.2 Cell Perfusion Systems Segment by Type
2.2.1 Recirculating Systems
2.2.2 Non-Recirculating Systems
2.3 Cell Perfusion Systems Sales by Type
2.3.1 Global Cell Perfusion Systems Sales Market Share by Type (2020-2025)
2.3.2 Global Cell Perfusion Systems Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cell Perfusion Systems Sale Price by Type (2020-2025)
2.4 Cell Perfusion Systems Segment by Application
2.4.1 Drug Development
2.4.2 Disease Modeling
2.4.3 Personalized Medicine
2.4.4 Others
2.5 Cell Perfusion Systems Sales by Application
2.5.1 Global Cell Perfusion Systems Sale Market Share by Application (2020-2025)
2.5.2 Global Cell Perfusion Systems Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cell Perfusion Systems Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Cell Perfusion Systems Breakdown Data by Company
3.1.1 Global Cell Perfusion Systems Annual Sales by Company (2020-2025)
3.1.2 Global Cell Perfusion Systems Sales Market Share by Company (2020-2025)
3.2 Global Cell Perfusion Systems Annual Revenue by Company (2020-2025)
3.2.1 Global Cell Perfusion Systems Revenue by Company (2020-2025)
3.2.2 Global Cell Perfusion Systems Revenue Market Share by Company (2020-2025)
3.3 Global Cell Perfusion Systems Sale Price by Company
3.4 Key Manufacturers Cell Perfusion Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cell Perfusion Systems Product Location Distribution
3.4.2 Players Cell Perfusion Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Cell Perfusion Systems by Geographic Region
4.1 World Historic Cell Perfusion Systems Market Size by Geographic Region (2020-2025)
4.1.1 Global Cell Perfusion Systems Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cell Perfusion Systems Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cell Perfusion Systems Market Size by Country/Region (2020-2025)
4.2.1 Global Cell Perfusion Systems Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cell Perfusion Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cell Perfusion Systems Sales Growth
4.4 APAC Cell Perfusion Systems Sales Growth
4.5 Europe Cell Perfusion Systems Sales Growth
4.6 Middle East & Africa Cell Perfusion Systems Sales Growth
5 Americas
5.1 Americas Cell Perfusion Systems Sales by Country
5.1.1 Americas Cell Perfusion Systems Sales by Country (2020-2025)
5.1.2 Americas Cell Perfusion Systems Revenue by Country (2020-2025)
5.2 Americas Cell Perfusion Systems Sales by Type (2020-2025)
5.3 Americas Cell Perfusion Systems Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Perfusion Systems Sales by Region
6.1.1 APAC Cell Perfusion Systems Sales by Region (2020-2025)
6.1.2 APAC Cell Perfusion Systems Revenue by Region (2020-2025)
6.2 APAC Cell Perfusion Systems Sales by Type (2020-2025)
6.3 APAC Cell Perfusion Systems Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cell Perfusion Systems by Country
7.1.1 Europe Cell Perfusion Systems Sales by Country (2020-2025)
7.1.2 Europe Cell Perfusion Systems Revenue by Country (2020-2025)
7.2 Europe Cell Perfusion Systems Sales by Type (2020-2025)
7.3 Europe Cell Perfusion Systems Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Perfusion Systems by Country
8.1.1 Middle East & Africa Cell Perfusion Systems Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cell Perfusion Systems Revenue by Country (2020-2025)
8.2 Middle East & Africa Cell Perfusion Systems Sales by Type (2020-2025)
8.3 Middle East & Africa Cell Perfusion Systems Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell Perfusion Systems
10.3 Manufacturing Process Analysis of Cell Perfusion Systems
10.4 Industry Chain Structure of Cell Perfusion Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cell Perfusion Systems Distributors
11.3 Cell Perfusion Systems Customer
12 World Forecast Review for Cell Perfusion Systems by Geographic Region
12.1 Global Cell Perfusion Systems Market Size Forecast by Region
12.1.1 Global Cell Perfusion Systems Forecast by Region (2026-2031)
12.1.2 Global Cell Perfusion Systems Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cell Perfusion Systems Forecast by Type (2026-2031)
12.7 Global Cell Perfusion Systems Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Repligen
13.1.1 Repligen Company Information
13.1.2 Repligen Cell Perfusion Systems Product Portfolios and Specifications
13.1.3 Repligen Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Repligen Main Business Overview
13.1.5 Repligen Latest Developments
13.2 Fluigent
13.2.1 Fluigent Company Information
13.2.2 Fluigent Cell Perfusion Systems Product Portfolios and Specifications
13.2.3 Fluigent Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Fluigent Main Business Overview
13.2.5 Fluigent Latest Developments
13.3 ibidi
13.3.1 ibidi Company Information
13.3.2 ibidi Cell Perfusion Systems Product Portfolios and Specifications
13.3.3 ibidi Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ibidi Main Business Overview
13.3.5 ibidi Latest Developments
13.4 Cytiva
13.4.1 Cytiva Company Information
13.4.2 Cytiva Cell Perfusion Systems Product Portfolios and Specifications
13.4.3 Cytiva Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cytiva Main Business Overview
13.4.5 Cytiva Latest Developments
13.5 Spectrum Medical
13.5.1 Spectrum Medical Company Information
13.5.2 Spectrum Medical Cell Perfusion Systems Product Portfolios and Specifications
13.5.3 Spectrum Medical Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Spectrum Medical Main Business Overview
13.5.5 Spectrum Medical Latest Developments
13.6 Elveflow
13.6.1 Elveflow Company Information
13.6.2 Elveflow Cell Perfusion Systems Product Portfolios and Specifications
13.6.3 Elveflow Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Elveflow Main Business Overview
13.6.5 Elveflow Latest Developments
13.7 Precigenome
13.7.1 Precigenome Company Information
13.7.2 Precigenome Cell Perfusion Systems Product Portfolios and Specifications
13.7.3 Precigenome Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Precigenome Main Business Overview
13.7.5 Precigenome Latest Developments
13.8 Merck KGaA
13.8.1 Merck KGaA Company Information
13.8.2 Merck KGaA Cell Perfusion Systems Product Portfolios and Specifications
13.8.3 Merck KGaA Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merck KGaA Main Business Overview
13.8.5 Merck KGaA Latest Developments
13.9 Harvard Apparatus
13.9.1 Harvard Apparatus Company Information
13.9.2 Harvard Apparatus Cell Perfusion Systems Product Portfolios and Specifications
13.9.3 Harvard Apparatus Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Harvard Apparatus Main Business Overview
13.9.5 Harvard Apparatus Latest Developments
13.10 Sartorius Stedim Biotech
13.10.1 Sartorius Stedim Biotech Company Information
13.10.2 Sartorius Stedim Biotech Cell Perfusion Systems Product Portfolios and Specifications
13.10.3 Sartorius Stedim Biotech Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sartorius Stedim Biotech Main Business Overview
13.10.5 Sartorius Stedim Biotech Latest Developments
13.11 AutoMate Scientific
13.11.1 AutoMate Scientific Company Information
13.11.2 AutoMate Scientific Cell Perfusion Systems Product Portfolios and Specifications
13.11.3 AutoMate Scientific Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 AutoMate Scientific Main Business Overview
13.11.5 AutoMate Scientific Latest Developments
13.12 REPROCELL
13.12.1 REPROCELL Company Information
13.12.2 REPROCELL Cell Perfusion Systems Product Portfolios and Specifications
13.12.3 REPROCELL Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 REPROCELL Main Business Overview
13.12.5 REPROCELL Latest Developments
13.13 Tokai HIT
13.13.1 Tokai HIT Company Information
13.13.2 Tokai HIT Cell Perfusion Systems Product Portfolios and Specifications
13.13.3 Tokai HIT Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Tokai HIT Main Business Overview
13.13.5 Tokai HIT Latest Developments
13.14 Biophysical Tools
13.14.1 Biophysical Tools Company Information
13.14.2 Biophysical Tools Cell Perfusion Systems Product Portfolios and Specifications
13.14.3 Biophysical Tools Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Biophysical Tools Main Business Overview
13.14.5 Biophysical Tools Latest Developments
13.15 3D Biotek
13.15.1 3D Biotek Company Information
13.15.2 3D Biotek Cell Perfusion Systems Product Portfolios and Specifications
13.15.3 3D Biotek Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 3D Biotek Main Business Overview
13.15.5 3D Biotek Latest Developments
13.16 TA Instruments
13.16.1 TA Instruments Company Information
13.16.2 TA Instruments Cell Perfusion Systems Product Portfolios and Specifications
13.16.3 TA Instruments Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 TA Instruments Main Business Overview
13.16.5 TA Instruments Latest Developments
13.17 Takasago Electric
13.17.1 Takasago Electric Company Information
13.17.2 Takasago Electric Cell Perfusion Systems Product Portfolios and Specifications
13.17.3 Takasago Electric Cell Perfusion Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Takasago Electric Main Business Overview
13.17.5 Takasago Electric Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂